1. Home
  2. FLXS vs FULC Comparison

FLXS vs FULC Comparison

Compare FLXS & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$74.99

Market Cap

327.6M

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

285.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLXS
FULC
Founded
2001
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
327.6M
285.4M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
FLXS
FULC
Price
$74.99
$3.77
Analyst Decision
Hold
Analyst Count
0
5
Target Price
★ $87.00
$3.67
AVG Volume (30 Days)
53.8K
★ 1.4M
Earning Date
10-26-2026
11-17-2026
Dividend Yield
★ 1.37%
N/A
EPS Growth
★ 70.99
N/A
EPS
★ 1.24
N/A
Revenue
★ $459,178,000.00
N/A
Revenue This Year
$3.48
N/A
Revenue Next Year
$5.29
N/A
P/E Ratio
$58.79
★ N/A
Revenue Growth
★ 4.10
N/A
52 Week Low
$34.50
$2.83
52 Week High
$90.65
$15.74

Technical Indicators

Market Signals
Indicator
FLXS
FULC
Relative Strength Index (RSI) 37.46 52.57
Support Level $72.11 $3.62
Resistance Level $78.44 $3.91
Average True Range (ATR) 3.59 0.07
MACD -1.34 0.01
Stochastic Oscillator 36.74 66.67

Price Performance

Historical Comparison
FLXS
FULC

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: